Status:
COMPLETED
Ultrasonographic Assessment of Carpal Tunnel Syndrome
Lead Sponsor:
University of Utah
Conditions:
Carpal Tunnel Syndrome
Eligibility:
All Genders
3-12 years
Brief Summary
Mucopolysaccharidosis are lysosomal storage disorders such as Hunter, Hurler, and Sanfilippo syndromes. These patients have a genetic enzyme deficiency that results in the inability to degrade glycosa...
Eligibility Criteria
Inclusion
- For the first arm of the study (25 participants):
- Children with mucopolysaccharidosis presenting to the senior author's clinic with signs or symptoms of carpal tunnel syndrome will be enrolled to receive both an EMG and carpal tunnel ultrasound of the upper extremities.
- For the second arm of the study (100 participants):
- Healthy children ages 3-12 with no acute upper extremity trauma or history of mucopolysaccharidosis.
- 25 additional participants requested in case of inconclusive ultrasound results, patient removal, or other unusable results.
Exclusion
- First arm:
- Children with mucopolysaccharidosis who have undergone previous treatment for carpal tunnel syndrome.
- Second arm:
- Acute (\<3month) wrist or hand surgery/injuries.
- Unable to obtain parental consent or patient assent.
- History of mucopolysaccharidosis.
- Non-english speaking.
- Cognitive impairment.
Key Trial Info
Start Date :
July 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2019
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT02196220
Start Date
July 1 2013
End Date
June 1 2019
Last Update
August 20 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Utah/Primary Children's Medical Center
Salt Lake City, Utah, United States, 84121